| Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease a placebo-controlled study of olanzapine and risperidone in dogs M Ader, SP Kim, KJ Catalano, V Ionut, K Hucking, JM Richey, M Kabir, ... Diabetes 54 (3), 862-871, 2005 | 232 | 2005 |
| Gastrointestinal hormones and bariatric surgery‐induced weight loss V Ionut, M Burch, A Youdim, RN Bergman Obesity 21 (6), 1093-1103, 2013 | 194 | 2013 |
| Mechanisms responsible for excess weight loss after bariatric surgery V Ionut, RN Bergman Journal of diabetes science and technology 5 (5), 1263-1282, 2011 | 110 | 2011 |
| Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones V Ionut, K Hucking, IF Liberty, RN Bergman Diabetologia 48, 967-975, 2005 | 90 | 2005 |
| Novel canine models of obese prediabetes and mild type 2 diabetes V Ionut, H Liu, V Mooradian, AVB Castro, M Kabir, D Stefanovski, D Zheng, ... American Journal of Physiology-Endocrinology and Metabolism 298 (1), E38-E48, 2010 | 77 | 2010 |
| Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver D Zheng, V Ionut, V Mooradian, D Stefanovski, RN Bergman Diabetes 58 (2), 352-359, 2009 | 57 | 2009 |
| Exenatide can reduce glucose independent of islet hormones or gastric emptying V Ionut, D Zheng, D Stefanovski, RN Bergman American Journal of Physiology-Endocrinology and Metabolism 295 (2), E269-E277, 2008 | 51 | 2008 |
| Consistency of the disposition index in the face of diet induced insulin resistance: potential role of FFA D Stefanovski, JM Richey, O Woolcott, M Lottati, D Zheng, LN Harrison, ... PLoS One 6 (3), e18134, 2011 | 48 | 2011 |
| Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action V Ionut, IF Liberty, K Hucking, M Lottati, D Stefanovski, D Zheng, ... American Journal of Physiology-Endocrinology and Metabolism 291 (4), E779-E785, 2006 | 44 | 2006 |
| Estimating hepatic glucokinase activity using a simple model of lactate kinetics D Stefanovski, JH Youn, M Rees, RM Watanabe, M Ader, V Ionut, ... Diabetes care 35 (5), 1015-1020, 2012 | 22 | 2012 |
| Investigation of the effect of acepromazine on intravenous glucose tolerance tests in dogs V Ionut, EL Kirkman, RN Bergman American journal of veterinary research 65 (8), 1124-1127, 2004 | 17 | 2004 |
| Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal D Zheng, V Ionut, V Mooradian, D Stefanovski, RN Bergman American Journal of Physiology-Endocrinology and Metabolism 298 (2), E346-E353, 2010 | 10 | 2010 |
| Deconvolution as a Novel Approach to Analyze Moment‐to‐Moment Free Fatty Acid Release K Hücking, IR Hsu, V Ionut, RN Bergman Obesity 15 (10), 2416-2423, 2007 | 3 | 2007 |
| Rimonabant reduces body weight and adiposity independent of changes in resting metabolic rate and food intake OO Woolcott, D Stefanovski, LN Harrison, V Mooradian, D Zheng, ... Diabetologia 51, S316-S316, 2008 | 2 | 2008 |
| Exenatide sensitizes insulin-mediated glucose uptake at skeletal muscle and liver D Zheng, V Ionut, V Mooradian, D Stefanovski, R Bergman JOURNAL OF INVESTIGATIVE MEDICINE 56 (1), 133-133, 2008 | 2 | 2008 |
| Portal GLP-1 produces an insulin-independent reduction in glycemia by increasing extrahepatic glucose disposal, without changing net hepatic glucose production V Ionut, D Stefanovski, M Lottati, D Zheng, EF Kirkman, RN Bergman DIABETES 55, A84-A84, 2006 | 1 | 2006 |
| Dietary Induced Weight Loss in Patients with Poorly Controlled Diabetes Is Associated with Rise in Adiponectin and Improved Glycemic Control E Beale, L WA, M Walker, K Konersman, A Peters, V Ionut Endocr Rev 33 (3), SUN-126, 2012 | | 2012 |
| Estimating Hepatic Glucokinase Activity From the FSIGT Using a Novel Working Model of Lactate Metabolism D Stefanovski, J Youn, M Ader, V Ionut, R Watanabe, RN Bergman OBESITY 18, S214-S214, 2010 | | 2010 |
| Insulin Sensitivity and Visceral Adiposity: Effects of Rimonabant JM Richey, M Kabir, OO Woolcott, SP Kim, LN Harrison, D Stefanovski, ... Abdominal Obesity and the Endocannabinoid System, 95-102, 2008 | | 2008 |
| Role of intestinal hormone glucagon-like peptide-1 (GLP-1) in glycemic regulation V Ionut University of Southern California, 2005 | | 2005 |
